JAAD Study Asks: Can Intralesional 5-FU Intervals Stretch in Low-Risk SCC?
JAAD's November 2026 issue (Vol. 95, No. 5) carries a retrospective cohort study by Hwang and colleagues on extended-interval intralesional 5-FU for low-risk squamous cell carcinoma.